1. bookVolumen 63 (2013): Edición 1 (March 2013)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Sustained release enteric coated tablets of pantoprazole: Formulation, in vitro and in vivo evaluation

Publicado en línea: 12 Mar 2013
Volumen & Edición: Volumen 63 (2013) - Edición 1 (March 2013)
Páginas: 131 - 140
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. S. W. Hosking, S. C. S. Chung, M. Y. Yung, A. K. C. Li, J. J. Y. Sung, T. K. W. Ling and A. F. B. Cheng, Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial, Lancet 343 (1994) 508- 510; DOI: 10.1016/S0140-6736(94)91460-5.10.1016/S0140-6736(94)91460-5Search in Google Scholar

2. J. Weil, D. Colin-Jones, M. Langman, D. Lawson, M. Murphy, M. Rawlins, M. Vessey and P. Wainwright, Prophylactic aspirin and risk of peptic ulcer bleeding, Br. Med. J. 310 (1995) 827-830.10.1136/bmj.310.6983.827Search in Google Scholar

3. G. Sachs, Proton pump inhibitors and acid-related diseases, Pharmacotherapy 17 (1997) 22-37. DOI: 10.1002/j.1875-9114.1997.tb03675.x.Search in Google Scholar

4. S. S. Ozturk, B. O. Palsson, B. Donohoe and J. B. Dressman, Kinetics of release from enteric- -coated tablets, Pharm. Res. 5 (1988) 550-565; DOI: 10.1023/A:1015937912504.10.1023/A:1015937912504Search in Google Scholar

5. Y. B. Huang, Y. H. Tsai, W. C. Yang, J. S. Chang, P. C. Wu and K. Takayama, Once-daily propranolol extended tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 58 (2004) 607-614; DOI: 10.1016/j.ejpb.2004.03.037.10.1016/j.ejpb.2004.03.037Search in Google Scholar

6. K. R. Reddy, S. Mutalik and S. Reddy, Once-daily sustained release matrix tablets of nicorandil: Formulation and in vitro evaluation,AAPS Pharm. Sci. Tech. 4 (2003) 480-488; DOI: 10.1208/pt040461.10.1208/pt040461Search in Google Scholar

7. B.Wilson, P. H. Sitarambhai, M. S. Sajeev and G. Vinothapooshan, Design and evaluation of sustained release matrix tablets of levofloxacin for effective treatment of microbial infection, Int. J. Drug Deliv. 3 (2011) 305-314.Search in Google Scholar

8. Pharmacopoeia of India, Ministry of Health and Family Welfare, Government of India, Controller of Publications, New Delhi 1996, pp. A80-A84.Search in Google Scholar

9. United States Pharmacopoiea 23, National Formulary 18, USP Convention, Rockville (MD) 1995, pp. 1328.Search in Google Scholar

10. K. Tahara, K. Yamamoto and T. Nishihata, Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methylcellulose sustained release tablets, Int. J. Pharm. 133 (1996) 17-27; DOI: 10.1016/0378- -5173(95)04400-0.Search in Google Scholar

11. P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci.13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

12. N. S. Parmar and J. K. Desai, A review of the current methodology for the evaluation of gastric and duodenal anti-ulcer agents, Indian. J. Pharmacol. 25 (1993) 120-135. 140Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo